Altimmune (ALT) Treasury Shares (2010 - 2026)

Altimmune (ALT) has 17 years of Treasury Shares data on file, last reported at $2.2 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $2.2 million, up 105.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (up 105.06% YoY), and the FY2025 annual result was $2.1 million, up 140.45% from the prior year.
• Treasury Shares rose to $2.2 million in Q1 2026 per ALT's latest filing, from $2.1 million in the prior quarter.
• Over five years, Treasury Shares peaked at $2.2 million in Q1 2026 and troughed at $13454.0 in Q3 2022.
• A 5-year average of $835965.7 and a median of $784227.0 in 2024 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares sank 93.52% in 2022, then surged 4497.47% in 2023.
• A 5-year view of Treasury Shares shows it stood at $414485.0 in 2022, then soared by 45.76% to $604167.0 in 2023, then surged by 42.06% to $858290.0 in 2024, then jumped by 140.45% to $2.1 million in 2025, then grew by 4.66% to $2.2 million in 2026.
• Business Quant data shows ALT's Treasury Shares at $2.2 million in Q1 2026, $2.1 million in Q4 2025, and $1.1 million in Q3 2025.